Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3
Open Access
- 27 May 2003
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 10 (6), 435-444
- https://doi.org/10.1038/sj.cgt.7700592
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3Molecular Therapy, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- AdTIMP-2 Inhibits Tumor Growth, Angiogenesis, and Metastasis, and Prolongs Survival in MiceHuman Gene Therapy, 2001
- E1B-Deleted Adenovirus (dl1520) Gene Therapy for Patients with Primary and Secondary Liver TumorsHuman Gene Therapy, 2001
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- Gene Transfer and Therapy with Adenoviral Vector in Rats with Diethylnitrosamine-Induced Hepatocellular CarcinomaHuman Gene Therapy, 1997
- Adenoviral Delivery of Recombinant DNA into Transgenic Mice Bearing Hepatocellular CarcinomasHuman Gene Therapy, 1996
- Modulation of the Organ Microenvironment for Treatment of Cancer MetastasisJNCI Journal of the National Cancer Institute, 1995
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970